App is temporarily unavailable
传审
Published by:
Chengdu HuaYiYun Technology Co
Description
我们是一款具有人文关怀的专业移动健康咨询应用 — 来自四川大学华西医院的医生鼎力担当平台创始医生团队。 同时，与重庆医科大学附属医院，附属儿童医院，第三军医大学新桥医院、西南医院、大坪医院等深度合作。我们立志借助移动互联网改善医患关系，提升医生个人价值及品牌。
传检/传审作为互联网+患者院外管理平台，主要提供术后患者和慢病患者的诊后服务，实现了患者随访的数字化，有助于医生追踪患者康复情况和远期疗效，提高临床医疗水平；
【在线服务】为患者提供（图文、语音）在线咨询、电话咨询、预约面诊、诊后随访、家庭医生等个性化医疗服务，助医生技能价值最大化，收入合理阳光。
【医学教育】超优三甲医院名医亲临授课，随时随地看专家讲课视频，碎片化时间学习。
【医生工作室】自主定价，精准匹配有效患者，患者数据随身携带，随时随地和患者交流，建立忠实的患者群，帮助医生打造个人品牌。
温馨提示：传审APP为医生专用，如果您是患者，请搜索下载“传检”客户端。
Hide
Show More...
传检/传审作为互联网+患者院外管理平台，主要提供术后患者和慢病患者的诊后服务，实现了患者随访的数字化，有助于医生追踪患者康复情况和远期疗效，提高临床医疗水平；
【在线服务】为患者提供（图文、语音）在线咨询、电话咨询、预约面诊、诊后随访、家庭医生等个性化医疗服务，助医生技能价值最大化，收入合理阳光。
【医学教育】超优三甲医院名医亲临授课，随时随地看专家讲课视频，碎片化时间学习。
【医生工作室】自主定价，精准匹配有效患者，患者数据随身携带，随时随地和患者交流，建立忠实的患者群，帮助医生打造个人品牌。
温馨提示：传审APP为医生专用，如果您是患者，请搜索下载“传检”客户端。
Screenshots
传审 FAQ
-
Is 传审 free?
Yes, 传审 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 传审 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 传审 cost?
传审 is free.
-
What is 传审 revenue?
To get estimated revenue of 传审 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Taiwan yet.
Ratings History
传审 Reviews
Keywords
传审 Installs
Last 30 days
传审 Revenue
Last 30 days传审 Revenue and Downloads
Gain valuable insights into 传审 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- Chengdu HuaYiYun Technology Co
- Languages
- Chinese
- Recent release
- 1.0.6 (1 year ago )
- Released on
- Oct 11, 2022 (2 years ago )
- Also available in
- Pakistan , Italy , Japan , South Korea , Kuwait , Kazakhstan , Lebanon , Mexico , Malaysia , Nigeria , Netherlands , Norway , New Zealand , Peru , Philippines , India , Poland , Portugal , Romania , Russia , Saudi Arabia , Sweden , Singapore , Thailand , Türkiye , Taiwan , Ukraine , United States , Vietnam , South Africa , Denmark , Argentina , Austria , Australia , Azerbaijan , Belgium , Brazil , Belarus , Canada , Switzerland , Chile , China , Colombia , Czechia , Germany , United Arab Emirates , Dominican Republic , Algeria , Ecuador , Egypt , Spain , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Hungary , Indonesia , Ireland , Israel
- Last Updated
- 1 year ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.